Jefferies Financial Group’s Soleno Therapeutics SLNO Stock Holding History

Jefferies Financial Group’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-29,304	Closed	-$1.36M	–	2165
2025 Q4	$1.36M	Buy	29,304 +12,004	+69%	+$658K	0.01%	951
2025 Q3	$1.17M	Buy	17,300 +3,300	+24%	+$245K	0.01%	812
2025 Q2	$1.17M	Sell	14,000 -999	-7%	-$74.8K	0.01%	677
2025 Q1	$1.07M	Sell	14,999 -9,015	-38%	-$439K	0.01%	787
2024 Q4	$1.08M	Sell	24,014 -11,281	-32%	-$585K	0.01%	858
2024 Q3	$1.78M	Buy	35,295 +204	+0.6%	+$9.77K	0.01%	628
2024 Q2	$1.43M	Sell	35,091 -800	-2%	-$33.9K	0.02%	642
2024 Q1	$1.54M	Buy	35,891 +800	+2%	+$36.2K	0.01%	675
2023 Q4	$1.41M	Buy	+35,091	New	+$998K	0.01%	834

Other funds holding SLNO

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

KCM

Khrom Capital Management Miami Beach, Florida $1.19B AUM 14.29% 1-Year Est. Return

Jefferies Financial Group's SLNO Position: Q1 2026 in Review

Jefferies Financial Group sold out of Soleno Therapeutics (SLNO) in Q1 2026, closing a stake of 29,304 shares — an estimated $1.36M sold.

Jefferies Financial Group first reported a position in SLNO in Q4 2023 and held it in 9 quarters. The position peaked at $1.78M in Q3 2024. 225 funds tracked by Wall St. Rank hold SLNO as of Q1 2026.

Jefferies Financial Group reported no remaining Soleno Therapeutics position as of Q1 2026 after selling out during the quarter.
Jefferies Financial Group sold 29,304 Soleno Therapeutics shares in Q1 2026, an estimated $1.36M.
Jefferies Financial Group first reported a position in Soleno Therapeutics in Q4 2023 and held it in 9 quarters.
Jefferies Financial Group's Soleno Therapeutics position peaked at $1.78M in Q3 2024.
225 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.